Skip to content

Evaluating the Effects of Test Food Consumption on Pre- and Post-meal Hunger

Evaluating the Effects of Test Food Consumption on Pre- and Post-meal Hunger - Evaluating the Effects of Test Food Consumption on Pre- and Post-meal Hunger

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000053670
Enrollment
20
Registered
2024-02-21
Start date
2024-02-22
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Male/female adults

Interventions

Intake of test food product 1. Intake of test food product 2.

Sponsors

Seisyukai Clinic, Seishukai Medical corporation
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Men and women aged between 50 and 70 years at the time of consent acquisition. 2. Subjects who regularly consume three solid meals per day. 3. Subjects who can consume four sticks of a load meal (Calorie Mate) in a single sitting. 4. Subjects who are able to participate in a test involving an overnight stay of 1 night and 2 days. 5. Subjects who can give informed consent to partake in this study, after being provided with an explanation of the protocol detail.

Exclusion criteria

Exclusion criteria: 1. Subjects who are taking medications (related to diabetes, gastrointestinal organs, or metabolism) more than twice a week, which may potentially affect the trial, and cannot restrict their use during the study period. 2. Subjects with dislikes or allergies to the ingredients of the test food. 3. Subjects with previous and/or current medical history of diabetes. 4. Subjects with previous and/or current medical history of gastrointestinal diseases and/or surgery. 5. Subjects with current immune diseases and/or those taking related medications. 6. Subjects who are participating in the other clinical trials and/or who have participated in the other clinical trials within 4 weeks prior to the current trial and/or who are planning to participate in the other clinical trials. 7. Subjects with previous and/or current medical history of serious diseases in heart, liver, kidney and/or digestive organs. 8. Subjects who are pregnant, breastfeeding, or intending to become pregnant during trial period. 9. Subjects with allergies to medications and/or food. 10. Subjects deemed unsuitable for participation in the trial by the principal investigator or sub-investigator.

Design outcomes

Primary

MeasureTime frame
Four items related to appetite (Visual Analogue Scale, VAS)

Secondary

MeasureTime frame
Four items regarding craving for specific foods (Visual Analogue Scale, VAS) One item related to spiciness (likert scale)

Countries

Japan

Contacts

Public ContactHayato Ouchi

Seisyukai Clinic, Seishukai Medical corporation Clinical trial division

chiken@seishukai.or.jp03-5827-0930

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026